About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Aster DM Healthcare Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
27-Jan-2025
31-Jan-2025
Quarterly Results & Interim Dividend
27-Nov-2024
29-Nov-2024
Preferential Issue of shares Inter-alia, to consider the following: 1. To evaluate and approve the proposal for issuance of equity shares by way of preferential allotment of up to 5% paid-up capital of the Company (on post issue basis), in accordance with the provisions of the Companies Act, 2013, SEBI Regulations and such other applicable laws subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company. 2. To consider conducting the postal ballot, to seek the approval of shareholders inter alia in respect of aforesaid proposal, if the same is approved by the Board.
17-Oct-2024
23-Oct-2024
Quarterly Results
25-Jul-2024
31-Jul-2024
Quarterly Results
23-May-2024
28-May-2024
Final Dividend & Quarterly Results
05-Apr-2024
12-Apr-2024
Interim Dividend & Special Dividend & Inter alia to: 1. consider declaration of interim dividend for the financial year 2023-24 2. consider declaration of special dividend on account of segregation of the GCC business through the sale by Affinity Holdings Pvt Ltd, a wholly owned material subsidiary of the Company of entities conducting business in the GCC region to Alpha GCC Holdings Limited.
02-Feb-2024
08-Feb-2024
Quarterly Results
07-Nov-2023
14-Nov-2023
Quarterly Results
08-Aug-2023
14-Aug-2023
Quarterly Results
19-May-2023
25-May-2023
Audited Results
08-Feb-2023
14-Feb-2023
Quarterly Results
03-Nov-2022
10-Nov-2022
Quarterly Results
05-Aug-2022
11-Aug-2022
Quarterly Results
16-May-2022
24-May-2022
Audited Results
01-Feb-2022
08-Feb-2022
Quarterly Results
08-Nov-2021
11-Nov-2021
Quarterly Results
03-Aug-2021
11-Aug-2021
Quarterly Results
15-Jun-2021
22-Jun-2021
Audited Results
19-Jan-2021
09-Feb-2021
Quarterly Results
30-Oct-2020
10-Nov-2020
Quarterly Results
Page
1
of
2
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.